Showing results (1401-1410 of 1,416) with videos related to
Sort By:
Pageof 142
Environmental Science & Technology|July 13, 2021
Variability and Time of Day Dependence of Ozone Photochemistry in Western Wildfire PlumesMichael A Robinson, Zachary C J Decker, Kelley C Barsanti, et al.Contemporary Clinical Trials|September 24, 2020
Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trialElizabeth A Kobe, David Edelman, Phillip E Tarkington, et al.The Journal of Infectious Diseases|June 30, 2021
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 InfectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.Mbio|October 14, 2020
From People to <i>Panthera</i>: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx ZooDenise McAloose, Melissa Laverack, Leyi Wang, et al.Nature Microbiology|April 28, 2022
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.Open Forum Infectious Diseases|July 6, 2022
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue DistributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotationsEugene Kolker, Alex F Picone, Michael Y Galperin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.Pageof 142